Partnering

Areas of Interest

We seek partners that have:

• Differentiated assets in hematology-oncology and solid tumors;
• I&I assets in diseases with high unmet needs;
• Innovative technologies and clinical-stage assets;
• Innovative assets in need of support in process design, manufacturing, and regulatory strategy;
• Opportunities to access the large and growing market in China; and
• Opportunities to establish or expand access in the U.S., Europe, and other markets

Partnering Capabilities

Our company was founded on a commitment to innovative science that benefits patients, and this remains a priority today. Our scale and ability to expedite clinical trials, allow us to work with partners to tackle an array of medical challenges, at various stages of product development and across the disease spectrum.

Global Clinical Leadership

We have demonstrated an ability to run global clinical trials enrolling patients in key markets to satisfy regulatory authorities in those markets. We are able to run large numbers of studies with meaningful time savings and innovative designs. We are uniquely able to access people in China who are interested in participating in studies.

State-of-the-Art Global Manufacturing

We have cutting-edge CMC, process design and manufacturing capabilities powered by deep scientific and technical expertise with proven results across a broad range of modalities. We offer flexible and tailored solutions to help with the design, approval, production and delivery of your innovative medicines to patients across global markets.  Visit Manufacturing | BeiGene to learn more.

World-Class, Science-Driven Commercial Team in Oncology

Our oncology commercial team is among the industry’s most productive, with unparalleled expertise in both hematological malignancies and solid tumors. With an innovative global presence spanning the U.S., Europe, Asia, Australia, and Latin America, we are strategically positioned to lead in key markets. In high-growth regions like China, we are the partner of choice, backed by a portfolio of 17 medicines. Our team thrives at scale, delivering transformative results while maintaining an unwavering commitment to integrity and impact in every market we serve.

Fit-for-Purpose Alliance Management

We have built an alliance management team with a commitment to creating alliance programs around the specific scientific, clinical, and commercial needs of each unique asset. Our teams bring to our partnerships the values of teamwork, transparent communication, and science-based, agile decision-making.

Our Partners

Working with organizations that share our patient-centric vision and our commitment to exceptional science ensures that together with our partners, we can help get treatments to those in need around the world.